Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
Authors:
- 10 October 2019
- journal article
- review article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 21 (11) , 86
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome of exertional intolerance, cardiac dysfunction, and fluid overload and is associated with significant morbidity and mortality.Keywords
This publication has 32 references indexed in Scilit:
- Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) TrialCirculation, 2015
- Albuminuria Is Independently Associated With Cardiac Remodeling, Abnormal Right and Left Ventricular Function, and Worse Outcomes in Heart Failure With Preserved Ejection FractionJACC: Heart Failure, 2014
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart FailureNew England Journal of Medicine, 2014
- The pathophysiology of heart failure with preserved ejection fractionNature Reviews Cardiology, 2014
- Spironolactone for Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2014
- 2013 ACCF/AHA Guideline for the Management of Heart FailureCirculation, 2013
- A Novel Paradigm for Heart Failure With Preserved Ejection FractionJACC, 2013
- Fibroblast growth factor-23: what we know, what we don't know, and what we need to knowNephrology Dialysis Transplantation, 2013
- High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetesDiabetologia, 2012
- Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rateHeart, 2010